Third generation of systemic adjuvants of immunity: experimental basis for adjuvant combinations.
D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000818:Animals; D000900:Anti-Bacterial Agents / Q000276:immunology; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001388:Aziridines / Q000276:immunology; D001500:BCG Vaccine / Q000627:therapeutic use; D001428:Bacterial Vaccines / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D007930:Leucine / Q000031:analogs & derivatives / Q000276:immunology; D051379:Mice; D011550:Pseudomonas aeruginosa / Q000276:immunology*; D013947:Thymosin / Q000276:immunology
D000276:Adjuvants, Immunologic; D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D001388:Aziridines; D001500:BCG Vaccine; D001428:Bacterial Vaccines; D013947:Thymosin; D007930:Leucine